TAKE · Take Solutions Ltd · Biotechnology & Drugs
TAKE · Take Solutions Ltd · Biotechnology & Drugs
As of 06 Nov close
52-week range
75.0% below 52-week high
52-week range: as of 06 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹30 Cr
Revenue YoY
PAT YoY
+216.5%
Operating margin
Revenue, last 5 quarters
P/E (TTM)
P/B
8.9
P/S (TTM)
3.1
Sector P/E
Not available from data source
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| TAKE (this stock) | 48.9 | 8.9 | +17.1% | +46.5% | 0 | 0.0% |
| Sun Pharmaceutical Industries | 38.6 | 5.6 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
| Divi's Laboratories * | 59.7 | 14.5 | +26.1% | +17.4% | 0 | +0.3% |
| Torrent Pharmaceuticals | 74.6 | 19.7 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
* Net margin, ROE, D/E and dividend yield for these companies come from RedixFi fundamentals; the data vendor had no values for them.
Promoter
stable
FII
falling 2q
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| date | canonicalSymbol | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| 2026-08-10 | TAKE | 772779 | 1 | STRONG | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedTAKE Limited, formerly TAKE Solutions Limited, submitted its annual report for FY2025-26, highlighting its transition into an AI-driven healthcare and wellness platform. The report emphasizes strategic focus on healthcare digitization, preventive care, and longevity solutions, supported by a robust risk management framework and internal financial controls. The company aims to leverage AI and digital health platforms to drive long-term value creation through diversified revenue streams.
- Strategic emphasis on AI-led healthcare transformation and digital health platforms.
- Focus on preventive healthcare adoption through initiatives like the One Minute Clinic.
- Expansion into wellness and longevity markets, including anti-ageing products and services.
- Robust risk management and internal financial controls as per regulatory standards.
Key takeaway: TAKE Limited is transitioning into a diversified AI-driven healthcare and wellness platform, focusing on digitization, preventive care, and longevity solutions, supported by strong governance and risk management frameworks.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Auditor Qualification (3 items); Regulatory Action (3 items); Default / Covenant Breach (2 items)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Auditor Qualification
3 occurrencesRecent (last 12 months)
The Statutory Auditors expressed a Qualified Opinion in their reports on the standalone and consolidated financial statements for the year ended 31 March 2026, relating to the recoverability of certain income-tax assets pending the outcome of tax proceedings.
Earlier (1-3 years ago)
The auditor issued a qualified opinion on the consolidated financial statements of TAKE Solutions Limited due to tax assets of INR 118.70 Million related to various assessment years.
The statutory auditors issued a qualified opinion on the standalone financial statements, noting that tax assets of ₹ 88.32 Million are shown in the statements.
Regulatory Action
3 occurrencesRecent (last 12 months)
The company received fines from NSE and BSE for delaying the appointment of the Company Secretary and Compliance Officer within 3 months, with penalties of Rs. 8,02,4 and Rs. 2,59,6 respectively.
Earlier (1-3 years ago)
The company was fined by BSE and NSE for delaying submission of financial results for the quarters ended June 30, 2024, and September 30, 2024, and for non-compliance in appointing a qualified Company Secretary/Compliance Officer.
TAKE Solutions Limited was fined by BSE and NSE for delaying the appointment of a Women Independent Director under SEBI (LODR) Regulations, 2015. The company paid the fines and appointed the director on February 14, 2023.
Default / Covenant Breach
2 occurrencesEarlier (1-3 years ago)
TAKE Solutions Limited has settled an OTS with lenders of the LLP after ICICI Bank Limited classified the loan accounts as NPA due to continuous defaults by the LLP.
The company has defaults in the repayment of the principal and interest amounts on the loans referred to above.
Routine disclosures
Internal Control Weakness
3 occurrencesRecent (last 12 months)
The audit report identifies a material weakness related to income tax assets (net) of Rs. 875.80 Lakhs, which are subject to disputes pending before various forums.
Earlier (1-3 years ago)
The Holding Company has a material weakness in internal financial controls over the assessment of impairment in carrying value of tax assets and in direct tax litigations pending before various forums.
TAKE Solutions Limited's auditor identified a material weakness in the subsidiary company's internal financial controls over the reconciliation of unbilled receivables and deferred revenue, which could lead to misstatements in assets, liabilities, and disclosures.
Contingent Liability
3 occurrencesRecent (last 12 months)
The company has contingent liabilities of ₹108.03 lakhs as of 31st March, 2026 related to direct tax matters, with recoverability dependent on pending tax litigation outcomes.
Earlier (1-3 years ago)
The company has contingent liabilities related to income tax demands and GST disputes, with ongoing appeals and disputes covering assessment years from 2011-12 to 2021-22. The company has not made provisions for these liabilities in its books.
The company received a notice from ICICI Bank on May 17, 2024, regarding the invocation of a corporate guarantee given to Navitas LLP amounting to Rs. 7.15 Crores.
Related-Party Transaction
2 occurrencesRecent (last 12 months)
The Company has entered into related party transactions during the review period.
Earlier (1-3 years ago)
The company has material related party transactions and outstanding balances with Asia Global Trading (Chennai) Private Limited, a company in which the promoter has a substantial interest.
Management & Board Governance
3 occurrencesRecent (last 12 months)
The company had less than six directors as of 31 March 2026 due to a delay in filling a vacancy caused by the resignation of a Whole-time Director, resulting in non-compliance with SEBI Listing Regulations 17(1)(a) and 17(1)(c).
Earlier (1-3 years ago)
Mr. Chella Gowrishankar, a Non-Independent Non-Executive Director, resigned effective March 7, 2025, causing the Board composition to fall below SEBI LODR requirements. Additionally, existing Independent Directors resigned in April and May 2025, further misaligning the Board composition with Regulation 17(1) of SEBI LODR. Ms. Shobana, a Whole-Time Director, resigned on October 5, 2024, leaving the Company without a Managing Director, CEO, Manager, or Whole-Time Director during the period, violating Section 203 of the Companies Act, 2013.
Multiple key management personnel and independent directors resigned effective June 2022, including Mr. N. Kumar, Mr. Srinivasan H.R., Ms. Uma Ratnam Krishnan, Mr. Venkataraman Murali, and others, with some appointments made subsequent to their resignations.
Promoter Share Pledge
1 occurrenceRecent (last 12 months)
7.0% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).